← FDA Drug Approvals (Drugs@FDA)
CABERGOLINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: RENATA · Approved 2026-06-15
Drug application
- FDA Application #
ANDA220309- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- CABERGOLINE
- Generic name
- CABERGOLINE
- Active ingredients
- CABERGOLINE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- RENATA
- Manufacturer
- Cranbury Pharmaceuticals, LLC
- First approval
- 2026-06-15
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown